Vaxart
VXRT · OTC
$0.49+$0.0145 (+3.05%)TodayMarket closed ·
Prev close $0.4755
Who owns VXRT
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 1.8% of VXRT’s shares.
- Finney (Michael Joseph)0.3%
- Lee (Phillip E.)0.3%
- Lo (Steven)0.2%
- Grasman (Jeroen Nicolaas)0.2%
- Next 6 largest institutions0.8%
- All other shareholders98.2%
| Holder | Shares | % of shares |
|---|---|---|
| Finney (Michael Joseph) | 702.84K | 0.29% |
| Lee (Phillip E.) | 631.62K | 0.26% |
| Lo (Steven) | 560.36K | 0.23% |
| Grasman (Jeroen Nicolaas) | 545.61K | 0.23% |
| Berg (Edward B) | 496.98K | 0.21% |
| Tucker (Sean N.) | 371.34K | 0.15% |
| Cummings (James F.) | 366.69K | 0.15% |
| Finney (Kevin) | 222.84K | 0.09% |
| Floroiu (Cezar Andrei) | 207.61K | 0.09% |
| Watson (William Mark) | 173.53K | 0.07% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| LUX IM Global Medtech | 64.91K | 0.03% |
| Guggenheim Active Allocation Fund | 715 | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $6.53K (1 trade) of VXRT on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Wheadon David E. | Award | 78.70K | — |
| Wheadon David E. | Award | 39.40K | — |
| Watson W. Mark | Award | 78.70K | — |
| Watson W. Mark | Award | 39.40K | — |
| BREITMEYER JAMES B | Award | 16.61K | — |
| BREITMEYER JAMES B | Award | 8.31K | — |
| Finney Kevin | Award | 78.70K | — |
| Finney Kevin | Award | 39.40K | — |
| HERON ELAINE J | Award | 78.70K | — |
| HERON ELAINE J | Award | 39.40K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.33M
- Days to cover
- 4.66
- % of shares outstanding
- 0.96%
- Average daily volume
- 499.84K
- Change since last report
- +0.9%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.